Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia

21 May 2015

Abstract excerpt

Aberrant DNA methylation is known to occur in cancer, including hematological malignancies such as acute myeloid leukemia (AML). However, less is known about whether specific methylation profiles characterize specific subcategories of AML. We examined this issue by using comprehensive high-throughput array-based relative methylation analysis (CHARM) to compare methylation profiles among patients in different AML...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Cancer-related gene regulation
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25996682
DOI: 10.1080/15592294.2015.1048060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemiaPMID 25996682Read ↗

DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical featuresSemantic proximity Read ↗

Genome-wide DNA methylome analysis reveals methylation subtypes with different clinical outcomes for acute myeloid leukemia patients.Semantic proximity Read ↗

DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML)Semantic proximity Read ↗

Histone Methylation Modification Patterns and Relevant M-RiskScore in Acute Myeloid LeukemiaSemantic proximity Read ↗

Integrative Analysis of Multi-Omics Identified the Prognostic Biomarkers in Acute Myelogenous LeukemiaSemantic proximity Read ↗

Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemiaSemantic proximity Read ↗

Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemiaSemantic proximity Read ↗

Demethylator phenotypes in acute myeloid leukemia.Semantic proximity Read ↗

Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical ImplicationsSemantic proximity Read ↗

DNA methylation-based prognostic biomarkers of acute myeloid leukemia patientsSemantic proximity Read ↗

Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia.Semantic proximity Read ↗

Genome Wide Analysis of Acute Myeloid Leukemia Reveal Leukemia Specific Methylome and Subtype Specific Hypomethylation of RepeatsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.